Denton Pharma, Inc.
Denton Pharma, Inc. appears in FDA public data with 4 recalls, 0 510(k) clearances, 1 FDA inspection, and 0 compliance actions on record. Its most recent recall (D-0056-2021, Class II) was initiated on October 8, 2020.
Summary
- Total Recalls
- 4
- 510(k) Clearances
- 0
- Inspections
- 1
- Compliance Actions
- 0
Recent Recalls
| Number | Class | Product | Date |
|---|---|---|---|
| D-0056-2021 | Class II | Metformin Hydrochloride Extended-Release Tablets USP 750 mg, 30 Tablets bottle, Rx Only, Time-Cap La | October 8, 2020 |
| D-0057-2021 | Class II | Metformin Hydrochloride Extended-Release Tablets, USP 500 mg, a) 30 count (NDC 70934-309-30); b) 60 | October 8, 2020 |
| D-0794-2020 | Class II | Ranitidine Tablets, USP 150 mg , a). 4 count bottle (NDC 70934-017-04), b). 20-count bottle (NDC 709 | December 20, 2019 |
| D-0795-2020 | Class II | Ranitidine Tablets, USP 300 mg a). 15-count bottles (NDC 70934-287-15), b). 90-count bottles (NDC 70 | December 20, 2019 |